hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Pill
RxNorm concept 1164653, clinical dose form group (scdg).
- RxCUI
- 1164653
- Term type
- Clinical dose form group (SCDG)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1164653 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- methenamine (IN, has ingredient)
- methylene blue (IN, has ingredient)
- phenyl salicylate (IN, has ingredient)
- hyoscyamine (IN, has ingredient)
- sodium phosphate, monobasic (IN, has ingredient)
- Phosphasal Pill (SBDG, has tradename)
- Urelle Pill (SBDG, has tradename)
- Uretron DS Pill (SBDG, has tradename)
- Uribel Pill (SBDG, has tradename)
- Ustell Pill (SBDG, has tradename)
- Urimar Reformulated Oct 2013 Pill (SBDG, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1164653 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1164653 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1164653. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.